Cite
HARVARD Citation
Gupta, R. et al. (2020). Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorectal Cancer. Oncologist. pp. 235-243. [Online].